You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 288 No. 4, July 24, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Patient-Physician Relationship/ Care
 •Treatment Adherence
 •Drug Therapy
 •Adherence
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Elderly Patients' Adherence to Statin Therapy

William B. Applegate, MD,MPH

JAMA. 2002;288:495-497.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of THE JOURNAL, 2 articles present important new data that indicate persistence of use of statin therapy declines remarkably over time in 2 different elderly cohorts.1-2 Benner and colleagues1 used data from both New Jersey Medicaid and Pharmaceutical Assistance to the Aged and Disabled programs (1990-1999) to determine adherence with prescribed medication over a given time interval. They also evaluated persistence, defined as the duration of time over which a patient continued to fill the statin prescriptions. Filled prescription intervals were used to calculate the proportion of days covered by a statin in each quarter of a year after initiation of therapy. In the study by Jackevicius and colleagues,2 several large databases from Ontario, Canada (1994-1998), were merged, including one of drug benefits, another of hospital discharge summaries, and another of health insurance benefits. In this latter study, adherence was calculated simply as . . . [Full Text of this Article]

Author Affiliation: Wake Forest University Health Sciences, Winston-Salem, NC.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Long-term Persistence in Use of Statin Therapy in Elderly Patients
Joshua S. Benner, Robert J. Glynn, Helen Mogun, Peter J. Neumann, Milton C. Weinstein, and Jerry Avorn
JAMA. 2002;288(4):455-461.
ABSTRACT | FULL TEXT  

Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes
Cynthia A. Jackevicius, Muhammad Mamdani, and Jack V. Tu
JAMA. 2002;288(4):462-467.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke
Colivicchi et al.
Stroke 2007;38:2652-2657.
ABSTRACT | FULL TEXT  

Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes
Pladevall et al.
Diabetes Care 2004;27:2800-2805.
ABSTRACT | FULL TEXT  

Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Gurwitz et al.
JAMA 2003;289:1107-1116.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.